ActX

Seattle, United States

ActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice.

$6.0M raised

Dec 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ActX raised?

ActX has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.

Who are ActX's investors?

ActX's investors include Keiretsu Capital, Keiretsu Forum, Puget Sound Venture Club, Alliance of Angels.

Where is ActX headquartered?

ActX is headquartered in Seattle, United States.

What does ActX do?

ActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice.

What stage is ActX at?

ActX is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 16, 2022.

MLA

"ActX — Funding & Investors." VCBacked, December 16, 2022, https://www.vcbacked.co/company/actx. Accessed July 2, 2026.

APA

VCBacked. (2022). ActX — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/actx

Wikipedia (cite web)

{{cite web |title=ActX — Funding & Investors |url=https://www.vcbacked.co/company/actx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 16, 2022.